OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2019
(2)
2016
(2)
2014
(2)
2024
(1)
2022
(1)
2012
(1)
2003
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Expression levels of the yeast alcohol acetyltransferase genes ATF1, Lg-ATF1, and ATF2 control the formation of a broad range of volatile esters.
Not available
S-EPMC194970
|
biostudies-literature
Cite
Characterization of the recombinant Brettanomyces anomalus β-glucosidase and its potential for bioflavouring.
Not available
S-EPMC6680314
|
biostudies-literature
Cite
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.
Not available
S-EPMC11046490
|
biostudies-literature
Cite
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.
Not available
S-EPMC4086934
|
biostudies-literature
Cite
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
Not available
S-EPMC6696692
|
biostudies-literature
Cite
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.
Not available
S-EPMC6738722
|
biostudies-literature
Cite
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.
Not available
S-EPMC3304520
|
biostudies-literature
Cite
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.
Not available
S-EPMC4223652
|
biostudies-literature
Cite
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Not available
S-EPMC4741360
|
biostudies-literature
Cite
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Not available
S-EPMC9639796
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets